<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>医麦客 | wechat-feeds</title><link>http://MzI0OTUwODU5Mg.favicon.privacyhide.com/favicon.ico</link><description>医麦客是一个聚焦转化医学、精准医疗和生物制药的专业媒体平台，持续关注体外诊断、抗体药物、细胞治疗、基因治疗等细分领域。为新生物医药医疗领域的企业发声，推动企业和行业的快速发展。</description><managingEditor> (hellodword)</managingEditor><pubDate>Mon, 08 Feb 2021 08:10:05 +0800</pubDate><image><url>http://MzI0OTUwODU5Mg.favicon.privacyhide.com/favicon.ico</url><title>医麦客 | wechat-feeds</title><link>http://MzI0OTUwODU5Mg.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>i-GONAD技术，开启原位基因编辑胚胎的新征程丨医麦猛爆料</title><link>https://mp.weixin.qq.com/s/SWxdncTmVOkRaQhJ6guu3g</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/bK2EFoTdFIsG2ibH8icMEmlSWoJEMkiaRnes93SavMKetdA9wyx9ibyGgawEU2gqbUzzPSbyBWzpiaNUAOKuDN1vxsQ/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>i-GONAD不仅可替代受精卵显微注射，在基因编辑效率上也可达到显微注射水平。]]></content:encoded><pubDate>Sun, 07 Feb 2021 21:45:25 +0800</pubDate></item><item><title>罗氏/Spark公布A型血友病基因疗法的最新临床数据丨医麦猛爆料</title><link>https://mp.weixin.qq.com/s/tOSv6XaPS4vOt8JCRDNPCQ</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/bK2EFoTdFIsG2ibH8icMEmlSWoJEMkiaRne5ChaYjHKCcTLdUYAAnIhcZvqsCNoBN8sYicwGGzSwS6lTbXZqqyldCg/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>A型血友病基因疗法现况]]></content:encoded><pubDate>Sun, 07 Feb 2021 21:45:25 +0800</pubDate></item><item><title>强强联合！拜耳联合CureVac生产新冠疫苗丨医麦猛爆料</title><link>https://mp.weixin.qq.com/s/BQrzTrLdSlvZjqMY6Hm0Fg</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/bK2EFoTdFIsG2ibH8icMEmlSWoJEMkiaRneUvmmL06rfCDicdIkEQ3GqdvDCAUZvG9GtnLbprQbPsVfHEMNXPpzjXA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>急需扩大的新冠疫苗产能]]></content:encoded><pubDate>Sun, 07 Feb 2021 21:45:25 +0800</pubDate></item><item><title>国内基因和细胞治疗蓬勃发展，CDMO业务有望进一步扩展丨峰客创见</title><link>https://mp.weixin.qq.com/s/vJ2s5D1yqkwkJhWWPDNIIA</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/bK2EFoTdFIsG2ibH8icMEmlSWoJEMkiaRneIicpzGNQETkS6UR1Nk7Zru2ya1eSZXxyc5JZOWooppGKica4EibzkoOMQ/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>峰客访谈 · 创见专栏]]></content:encoded><pubDate>Sun, 07 Feb 2021 21:45:25 +0800</pubDate></item><item><title>里程碑达成丨金斯瑞蓬勃生物助力庄亚生物生产的200L GMP凝血因子VIII完成交付</title><link>https://mp.weixin.qq.com/s/L37cqMqL55EybGA_E2rV1A</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/bK2EFoTdFIsG2ibH8icMEmlSWoJEMkiaRnefoUZtn6QgT3a7Qu1xZctd2OVXkIJxB73k4Rujnz1gkY9xiaj9niaWddg/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>内容涵盖了单克隆筛选、工艺开发、分析方法开发及GMP生产。]]></content:encoded><pubDate>Sun, 07 Feb 2021 11:09:18 +0800</pubDate></item><item><title>药融资丨原能生物完成3.4亿元战略融资，推进生物智能装备制造及完善服务体系建设</title><link>https://mp.weixin.qq.com/s/8Z5ngZe4ztZ2DYkYSh_FNg</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/bK2EFoTdFIsG2ibH8icMEmlSWoJEMkiaRneXfghqoJdxICcDUBaJ0YfqA9tM4MPkuevwrwLwgUIDib4svvOgqibX0fg/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>原能生物启动全球化销售渠道合作及服务网络建设，将这一原创性且填补行业空白的高标准、智能化装备加快推进市场。]]></content:encoded><pubDate>Sun, 07 Feb 2021 11:09:18 +0800</pubDate></item><item><title>西湖生物医药与南京维立志博达成合作，开发多款携带抗体药物的工程化红细胞丨医麦猛爆料</title><link>https://mp.weixin.qq.com/s/z96P-d0WnlFsQzwjCCSUeA</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/bK2EFoTdFIsG2ibH8icMEmlSWoJEMkiaRneXzV9MOBRzkfGcViaKFRFlwZ2A3E7PDxp32b95GDXicoxYI3p3jibcKcEA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>]]></content:encoded><pubDate>Sun, 07 Feb 2021 11:09:18 +0800</pubDate></item><item><title>第四款CAR-T获得FDA批准上市！BMS重金收购而来的CAR-T细胞产品终于成功上市！丨医麦猛爆料</title><link>https://mp.weixin.qq.com/s/2ifICu304kllgu1RHaRZXA</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/bK2EFoTdFIsG2ibH8icMEmlSWoJEMkiaRneElNKMqzHFFV3AEeibc1X3FxWR81240HdheEa1QibUg55K9vkzW9icdJlg/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>全球CAR-T市场又迎来一位重量级玩家！]]></content:encoded><pubDate>Sun, 07 Feb 2021 11:09:18 +0800</pubDate></item><item><title>抗独特型抗体在抗体药物研发过程中发挥重要作用，不得不看的《抗独特型抗体开发实用手册》丨医麦猛爆料</title><link>https://mp.weixin.qq.com/s/Iyw9o-zZEKbwHyIwm-h2fg</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/bK2EFoTdFItZhnbVZlJpG0UXjU3UAkpp0t4zDaEB2Z2ibM3e9wXRO1zqVyuFUwhVKHvQ4FPSgReUicb8A8aDPXuw/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>热门手册，一键下载]]></content:encoded><pubDate>Fri, 05 Feb 2021 18:22:13 +0800</pubDate></item><item><title>吉利德2020财报：瑞德西韦为吉利德带来巨大现金流，CAR-T和ADC药物是吉利德的未来主要驱动力丨医麦猛爆料</title><link>https://mp.weixin.qq.com/s/-QxF_egRoZc5ll_fytcw9w</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/bK2EFoTdFItZhnbVZlJpG0UXjU3UAkppCZErFvXzgR0LX0CoYuQxAAmfojMaQibPL04mLvMLzibwAujBuiaHx4uJA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>CAR-T全球市场突破10亿美元]]></content:encoded><pubDate>Fri, 05 Feb 2021 18:22:13 +0800</pubDate></item><item><title>早期临床数据显示iNKT治疗重度新冠肺炎有效，75%的患者成功拔管出院丨医麦猛爆料</title><link>https://mp.weixin.qq.com/s/Sxg-u-oKvI-aowVXUz1qdA</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/bK2EFoTdFItZhnbVZlJpG0UXjU3UAkppEvPqpgPQyY6bPhDEMdJWHArJicFk5Kv7YaTJ0lIpa4CsLMeMFiczgF1Q/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>细胞治疗新冠肺炎]]></content:encoded><pubDate>Fri, 05 Feb 2021 18:22:13 +0800</pubDate></item><item><title>Nat Biotech | CAR-T专利格局：澳门大学胡元佳团队利用专利大数据深入分析CAR-T全球研发生态</title><link>https://mp.weixin.qq.com/s/26SqApCV43QRy6sYWs1b1A</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/bK2EFoTdFIt8Y2RibubUOJmGSibJ3bTg2h0Oo84dbLIrnd8pqLY17MghTugejEf82IGPkOaBEVLdI91ibNzt7Wqag/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>CAR-T专利布局至关重要]]></content:encoded><pubDate>Thu, 04 Feb 2021 23:27:59 +0800</pubDate></item><item><title>三款BiTE候选双抗停止临床研究！喜忧参半的安进2020财报丨医麦猛爆料</title><link>https://mp.weixin.qq.com/s/y52sKCHNPw3Z-dmwlTZHGw</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/bK2EFoTdFIt8Y2RibubUOJmGSibJ3bTg2hJp8fNJe5rlYk9ib2F3ZKibHJMfKoibAbPLzyF32dxaLwKmxcv9Pdr8zbA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>国内双抗正蓬勃发展]]></content:encoded><pubDate>Thu, 04 Feb 2021 23:27:59 +0800</pubDate></item><item><title>祐和医药与君实生物合作数据亮眼，CD40联用PD-1大放异彩丨医麦猛爆料</title><link>https://mp.weixin.qq.com/s/8ivhF6OtCTuzkNn_qbyH1g</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/bK2EFoTdFIt8Y2RibubUOJmGSibJ3bTg2hyhoewBACibSyYEwEYFzxIJmKQ2XgpoWTmKz051cnxaXNR51Aeib5JLXg/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>联用策略发挥更好的治疗效果]]></content:encoded><pubDate>Thu, 04 Feb 2021 23:27:59 +0800</pubDate></item><item><title>治疗镰状细胞病，更安全的慢病毒基因疗法获欧盟优先药物称号，能够在低清髓预处理的情况下发挥作用丨医麦猛爆料</title><link>https://mp.weixin.qq.com/s/pxFPuo5Kun1iko6uSnClgA</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/bK2EFoTdFIt8Y2RibubUOJmGSibJ3bTg2hSrp8MXxuibJxc6SkMycIyYPU4Pr32mWnaIltmP6wsJaibEuIwOOibbSMw/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>SCD基因疗法进展]]></content:encoded><pubDate>Thu, 04 Feb 2021 23:27:59 +0800</pubDate></item><item><title>在全球创新环境下，生物制药公司如何转型与突围丨峰客洞见</title><link>https://mp.weixin.qq.com/s/0YUJOLFAfrOSWgGa0asW3Q</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/bK2EFoTdFIsqddepUaYgLuDucwrRlGyPpX6ziaGpPSc1onvIfpicWagZ0SfVBCOzjWdoOs5BcUicSnUCqcKBY0miaQ/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>峰客访谈 · 洞见专栏]]></content:encoded><pubDate>Wed, 03 Feb 2021 23:47:03 +0800</pubDate></item><item><title>方达医药新增6200平方米实验室，扩张大分子生物分析和中心实验室业务，新建药物活性筛选生物实验室</title><link>https://mp.weixin.qq.com/s/r0Rn3SWMPmoQMCbZ1ldtYw</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/bK2EFoTdFIsqddepUaYgLuDucwrRlGyPyVSwIa510ticLorgkL8oS1FQp3KIyCc1jkrG4HOoYG7jC4Lib7aPTVAA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>预计2021年下半年投入使用]]></content:encoded><pubDate>Wed, 03 Feb 2021 23:47:03 +0800</pubDate></item><item><title>靶向CDH6！第一三共第6款Dxd ADC启动临床试验丨医麦猛爆料</title><link>https://mp.weixin.qq.com/s/dcJx7ty8GNHr_zGnZ7FGaQ</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/bK2EFoTdFIsqddepUaYgLuDucwrRlGyPA1iacBqStt7icPS1miaTouYyq4ygicibu0WnfB8dpZa5dUfv3oOZLKTjtibw/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>first-in-class]]></content:encoded><pubDate>Wed, 03 Feb 2021 23:47:03 +0800</pubDate></item><item><title>药融资丨Krystal拟募集1亿美元，推进皮肤病基因疗法</title><link>https://mp.weixin.qq.com/s/BmA2_ZFYSV9SVEflVcPVyw</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/mW6rQAOYFI6JjN8LEHo9E7P9gp1hpuW9OMNZaic7ZrlZ5vNdZr9QENN2KauoHkTbz2DHKemN67zUSlYLXOo6EDw/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>专利基因治疗平台由工程HSV-1载体和皮肤优化基因转移技术组成。]]></content:encoded><pubDate>Wed, 03 Feb 2021 23:47:03 +0800</pubDate></item><item><title>探索政企合作创新之路，打造生物产业良性生态——丹纳赫生命科学联合火石创造、高瓴资本圆满举办第一届中国生物产业园区合作发展高峰论坛</title><link>https://mp.weixin.qq.com/s/xLsCTu_S64XhXUmhlFxMCA</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/bK2EFoTdFIsqddepUaYgLuDucwrRlGyPJmZTwmNqibHz39ILuSn30ODgSWVQMQyuxIGMcrtBxiaOm60AqNMjTaYQ/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>共话中国生物医药产业]]></content:encoded><pubDate>Wed, 03 Feb 2021 16:11:35 +0800</pubDate></item></channel></rss>